Welcome to our dedicated page for Fairfax Finl SEC filings (Ticker: FRFHF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Fairfax Finl's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Fairfax Finl's regulatory disclosures and financial reporting.
Fairfax Financial Holdings filed a Form 6-K highlighting a definitive agreement for Kennedy-Wilson Holdings to be taken private by a consortium led by Kennedy Wilson CEO William McMorrow and senior executives, together with Fairfax. The consortium will acquire all outstanding common shares of Kennedy Wilson (other than shares held by the consortium and affiliates) for $10.90 per share in cash, a 46% premium to the company’s unaffected share price on November 4, 2025.
Fairfax has committed up to $1.65 billion to fund the cash purchase price, redemption of preferred shares not owned by the consortium, and certain other amounts under the merger agreement, and the transaction is not subject to a financing condition. After closing, Fairfax is expected to hold a majority of the economic interest in Kennedy Wilson, while the management group will retain effective and operational control. Closing is targeted for the second quarter of 2026, subject to stockholder and regulatory approvals. Upon completion, Kennedy Wilson’s shares will be delisted from the NYSE and deregistered, and the company will not host earnings calls for the fourth quarter 2025 or subsequent quarters while the transaction is pending.
Fairfax Financial Holdings Ltd. filed a Form 13F reporting institutional holdings managed by its investment unit. The report lists 29 holdings with an aggregate reported market value of $2,083,409,107. It also names 2 other included managers (Hamblin Watsa Investment Counsel Ltd and Watsa V Prem et al.).
Fairfax Financial Holdings Limited has scheduled a conference call to discuss its 2025 year-end results. The call will take place at 8:30 a.m. Eastern Time on Friday, February 20, 2026, following the release of results after markets close on Thursday, February 19, 2026.
Investors can access the call by dialing 1 (800) 369-2143 in Canada and the U.S. or 1 (312) 470-0063 internationally, using the passcode “FAIRFAX”. A replay will be available until 5:00 p.m. Eastern Time on Friday, March 20, 2026 at (866) 360-3309 in Canada and the U.S. or 1 (203) 369-0164 internationally.
Fairfax is a holding company that operates mainly in property and casualty insurance, reinsurance, and related investment management through its subsidiaries.
Fairfax Financial Holdings Ltd. filed a Form 13F reporting institutional holdings. The report lists 29 holdings with a total value of $2,064,595,933 and names 2 other included managers.
The filing is signed by Peter Clarke, Vice President and Chief Operating Officer, dated 11-14-2025.
Fairfax Financial Holdings Limited, a Canadian-based foreign private issuer, has filed a Form 6-K for November 2025. The filing mainly serves to furnish investors with two key documents: a November 6, 2025 news release detailing financial results for the third quarter and the company’s 2025 Third Quarter Interim Report.
The interim report, filed as Exhibit 99.2, is also incorporated by reference into Fairfax’s Form F-10 shelf registration statement, allowing it to be used as part of the disclosure package for potential future securities offerings in the United States.